Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.34 |
| ▸ | HTR3B | O95264 | 2/20 | 0.34 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.34 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.34 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.34 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL10460281 | 0.93 | HTR3A (0.35) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| Fumaric Acid SCHEMBL10460283 | 0.93 | HTR3A (0.35) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| SCHEMBL8962746 | 0.78 | HTR3A (0.39) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| SCHEMBL9597484 | 0.77 | HTR3A (0.39) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| SCHEMBL7430515 | 0.77 | HTR3A (0.38) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| Hydrochloric Acid SCHEMBL10460586 | 0.76 | CASP6 (0.39) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| Galdansetron SCHEMBL4564582 | 0.76 | KCNH2 (0.61) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| Galdansetron SCHEMBL635736 | 0.76 | KCNH2 (0.61) | HTR3ACYP3A4KCNH2CYP1A2HTR2B | |
| SCHEMBL7432628 | 0.76 | HSP90AA1 (0.40) | CYP3A4ADRA2CADRA1A | |
| Galdansetron SCHEMBL636713 | 0.75 | CASP6 (0.62) | HTR3ACYP3A4KCNH2CYP1A2HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5530008-A | USEFUL FOR TREATING ANXIETY DISORDER AND AGORAPHOBIA | SANDOZ LTD. (CH) | 1996-06-25 | — | — | US | claimed |
| EP-0422154-B1 | THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS | SANDOZ AG (AT) | 1993-12-01 | — | — | EP | claimed |
| US-4939144-A | PSYCHOLOGICAL DISORDERS; ANXIOLYTIC AND ANTIEMETIC AGENTS | GLAXO GROUP LIMITED (GB) | 1990-07-03 | — | — | US | claimed |
| US-5530008-A | USEFUL FOR TREATING ANXIETY DISORDER AND AGORAPHOBIA | SANDOZ LTD. (CH) | 1996-06-25 | — | — | US | disclosed |
| EP-0422154-B1 | THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS | SANDOZ AG (AT) | 1993-12-01 | — | — | EP | disclosed |
| EP-0422154-A1 | THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS. | SANDOZ AG (AT) | 1991-04-17 | — | — | EP | disclosed |
| WO-1990012569-A1 | THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS | SANDOZ AG (CH) | 1990-11-01 | — | — | WO | disclosed |
| US-4939144-A | PSYCHOLOGICAL DISORDERS; ANXIOLYTIC AND ANTIEMETIC AGENTS | GLAXO GROUP LIMITED (GB) | 1990-07-03 | — | — | US | disclosed |
| EP-0317088-A1 | Ketone derivatives | GLAXO GROUP LIMITED (GB) | 1989-05-24 | — | — | EP | disclosed |